Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Celgene“
Suchtreffer
Begriffe & Kennungen
Thalidomide BMS (previously Thalidomide Celgene) · 4.8 · 12 System Organ Class Frequency Adverse reaction
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 13 Table 4: Comparison of haematological disorders for the melphalan, prednisone (MP) and melphalan, prednison
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 14 Reporting of suspected adverse reactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) AML and MDS were reported in one clinical st
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Additional adverse reactions from post-marketing experience with thalidomide and not seen in the pivotal study
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Allergic reactions and severe skin reactions Cases of allergic reactions including angioedema, anaphylactic re
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Blood and lymphatic system disorders Adverse reactions for haematological disorders are provided compared to t
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Common Pneumonia Infections and infestations Severe infections (e.g. fatal sepsis including septic Not Known s
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Description of selected adverse reactions
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Elderly population
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Frequencies are defined as: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1000 to < 1/100);
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · In addition to the adverse reactions outlined above, thalidomide in combination with dexamethasone in other cl
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Most patients taking thalidomide can be expected to experience adverse reactions. The most commonly observed a
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Neutropenia, Leukopenia, Anaemia, Lymphopenia, Blood and lymphatic system Very Common Thrombocytopenia disorde
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Peripheral neuropathy Peripheral neuropathy is a very common, potentially severe, adverse reaction of treatmen
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Posterior reversible encephalopathy syndrome (PRES)/Reversible posterior leukoencephalopathy syndrome (RPLS) C
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Summary of the safety profile
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · System Organ Class Frequency Adverse reaction
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · Table 3 contains only the adverse reactions for which a causal relationship with medicinal product treatment c
Eintrag öffnen